腫瘍病理鑑別診断アトラス　皮膚腫瘍　II

出版社： 文光堂
著者：
発行日： 2010-11-25
分野： 臨床医学：基礎  >  臨床病理学
ISBN： 9784830622298
シリーズ： 腫瘍病理鑑別診断アトラス
電子書籍版： 2010-11-25 （第1版第2刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

16,500 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

16,500 円(税込)

購入する

商品紹介

2分冊のII巻目となる本書では，メラノサイト系腫瘍とリンパ・組織球・造血系腫瘍を取り上げ，WHO分類の矛盾点を整理・訂正して組織分類を呈示し，アトラスとして明快に解説。

目次

  • 皮膚腫瘍 II

    ―目次―

    第1部　検鏡前の確認事項
    　I．メラノサイト系腫瘍とリンパ・組織球・造血系腫瘍の分類
    　　1．メラノサイト系腫瘍の分類
    　　2．リンパ・組織球・造血系腫瘍の分類
    　II．病理標本の取扱い方
    　　1．メラノサイト系腫瘍を念頭に置いた摘出材料の取扱い
    　　2．リンパ球・組織球・造血系腫瘍を念頭に置いた取扱い

    第2部　組織型と診断の実際
    　I．メラノサイト系腫瘍
    　　1．良性腫瘍および腫瘍類似病変：母斑細胞母斑
    　　2．悪性腫瘍：悪性黒色腫
    　II．リンパ・組織球・造血系腫瘍
    　　1．良性腫瘍および腫瘍類似病変
    　　2．悪性腫瘍

    第3部　鑑別ポイント
    　I．メラノサイト系腫瘍で問題となる疾患の鑑別
    　　1．Spitz母斑と悪性黒色腫
    　　2．悪性黒色腫と先天性母斑
    　　3．異形成母斑と悪性黒色腫
    　　4．線維形成性黒色腫と線維形成性Spitz母斑
    　　5．先天性母斑に発生する増殖結節と悪性黒色腫
    　　6．Meyerson母斑と湿疹
    　　7．単純黒子と日光色素斑
    　II．メラノサイト系腫瘍の免疫組織化学
    　　1．メラノサイト系マーカーについて
    　　2．正常のメラノサイトの免疫組織化学
    　　3．母斑細胞性母斑における免疫組織化学
    　　4．悪性黒色腫における免疫組織化学
    　　5．未分化腫瘍の鑑別
    　III．リンパ・組織球・造血系腫瘍で問題となる疾患の鑑別
    　　1．菌状息肉症と扁平苔癬とその他の炎症
    　　2．表皮内浸潤を伴う皮膚悪性リンパ腫の鑑別
    　　3．辺縁帯B細胞リンパ腫と皮膚形質細胞増加症
    　　4．皮下脂肪織を侵すリンパ腫の鑑別
    　　5．血管内大細胞型B細胞リンパ腫と反応性血管内皮細胞腫症
    　　6．Langerhans細胞組織球症と肥満細胞症
    　　7．Rosai-Dorfman病と若年性黄色肉芽腫
    　IV．リンパ・組織球・造血系腫瘍の免疫組織化学
    　　1．リンパ・組織球・造血器腫瘍と他細胞系腫瘍の鑑別
    　　2．リンパ・組織球・造血器腫瘍の鑑別
    　　3．リンパ系腫瘍の鑑別

    第4部　臨床との連携
    　I．ダーモスコピーによる色素性病変の鑑別
    　II．皮膚原発悪性黒色腫の病期分類と病期別治療指針
    　III．皮膚原発悪性黒色腫の治療効果判定基準
    　IV．リンパ・造血系腫瘍における病期の判定と病期別治療方針
    　V．リンパ・組織球・造血系腫瘍における治療効果判定
    　VI．病理診断報告書の記載

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1部 検鏡前の確認事項

P.9 掲載の参考文献
1) LeBoit PE, Burg G, Weedon D et al (eds) : World Health Organization Classification of Tumours, Pathology & Genetics, Skin Tumours. IARC Press, Lyon, 2006, pp49-119, pp165-228
 
2) 清水宏 : あたらしい皮膚科学. 中山書店, 2005, pp248-249, pp420-423
 
3) Kempf W, Sander CA : Classification of cutaneous lymphomas-an update. Histopathology 56 : 57-70, 2010
PubMed
4) Elder DE (ed) : Lever's Histopathology of the Skin. Lippincott Williams & Wilkins, Philadelphia, 2009, pp182-183, pp699-789
 
5) Weedon D : Weedon's Skin Pathology. Churchill Livingstone, New York, 2010, pp84-86, p119, pp709-756
 
6) Busam KJ (ed) : Dermatopathology. Saunders Elsevier, Philadelphia, 2010, pp437-498
 
7) Arumi-Uria M, McNutt NS, Finnerty B : Grading of atypia in nevi : Correlation with melanoma risk. Mod Pathol 16 : 764-771, 2003
PubMed
8) 泉美貴 : みき先生の皮膚病理診断ABC (3) メラノサイト系病変. 秀潤社, 2007, pp58-65, pp93-137
 
9) National Institutes of Health Consensus Development Conference Statement on Diagnosis and Treatment of Early Melanoma, January 27-29, 1992. Am J Dermatopathol 15 : 34-43, 1993
PubMed
10) Tripp JM, Kopf AW, Marghoob AA et al : Management of dysplastic nevi : a survey of fellows of the American Academy of Dermatology. J Am Acad Dermatol 46 : 674-682, 2002
PubMed
11) Zembowicz A, Carney JA, Mihm MC : Pigmented epithelioid melanocytoma : a low-grade melanocytic tumor with metastatic potential indistinguishable from animal-type melanoma and epithelioid blue nevus. Am J Surg Pathol 28 : 31-40, 2004
PubMed
12) Zembowicz A, Knoepp SM, Bei T et al : Loss of expression of protein kinase a regulatory subunit 1α in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions. Am J Surg Pathol 31 : 1764-1775, 2007
 
13) Mandal RV, Murali R, Lundquist KF et al : Pigmented epithelioid melanocytoma : favorable outcome after 5-year follow-up. Am J Surg Pathol 33 : 1778-1782, 2009
PubMed
14) Ito K, Mihm MC : Pigmented epithelioid melanocytoma : report of first Japanese cases previously diagnosed as cellular blue nevus. J Cutan Pathol 36 : 439-443, 2009
PubMed
15) Ackerman AB, David KM : A unifying concept of malignant melanoma : biologic aspects. Hum Pathol 17 : 438-440, 1986
PubMed
16) Weyers W, Euler M, Diaz-Cascajo C et al : Classification of cutaneous malignant melanoma : a reassessment of histopathologic criteria for the distinction of different types. Cancer 86 : 288-299, 1999
PubMed
17) Harris NL, Jaffe ES, Stein H et al : A revised European-American classification of lymphoid neoplasms : a proposal from the International Lymphoma Study Group. Blood 84 : 1361-1392, 1994
 
18) Willemze R, Kerl H, Sterry W et al. : EORTC classification for primary cutaneous lymphomas : a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 90 : 354-371, 1997
 
19) Jaffe ES, Harris NL, Stein H et al (eds) : World Health Organization Classification of Tumours, Pathology & Genetics, Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, 2001, pp9-13
 
20) Willemze R, Jaffe ES, Burg G et al : WHO-EORTC classification for cutaneous lymphomas. Blood 105 : 3768-3785, 2005
PubMed
21) Swerdlow SH, Campo E, Harris NL et al (eds) : WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC, Lyon, 2008, pp9-15
 
P.15 掲載の参考文献
1) 日本皮膚悪性腫瘍学会 (編) : 皮膚悪性腫瘍取扱い規約, 第1版. 金原出版, 2002, p17
 
2) 日本皮膚悪性腫瘍学会 (編) : 皮膚悪性腫瘍取扱い規約, 第1版. 金原出版, 2002, p24
 
3) 日本皮膚悪性腫瘍学会 (編) : 皮膚悪性腫瘍取扱い規約, 第2版. 金原出版, 2010, p28
 
4) 池田重雄 (監修) : カラーアトラスDermoscopy. 金原出版, 2003
 
5) Cochran AJ, Roberts AA, Saida T : The place of lymphatic mapping and sentinel node biopsy in oncology. Int J Clin Oncol 8 : 139-150, 2003
PubMed
6) LeBoit PE, Burg G, Weedon D et al : World Health Organization Classification of Tumours. Pathology & Genetics ; Skin Tumours. IARC Press, Lyon, 2006
 
7) Willemze R, Jaffe ES, Burg G et al : WHO-EORTC classification for cutaneous lymphomas. Blood 105 : 3768-3785, 2005
PubMed
8) 日本皮膚悪性腫瘍学会 (編) : 皮膚悪性腫瘍取扱い規約, 第1版. 金原出版, 2002, p107
 

第2部 組織型と診断の実際

P.24 掲載の参考文献
1) Bolognia JL, Orlow SJ : Melanocyte biology. in Bolognia JL, Jorizzo JL, Rapini RP (eds) : "Dermatology". Mosby, London, 2003, pp935-945
 
2) Fitzpatrick TB, Szabo G : The melanocyte : cytology and cytochemistry. J Invest Dermatol 32 : 197-209, 1959
PubMed
3) Quevedo WC, Szavo G, Virks J : Influence of age and UV on the population of dopa-positive malenocytes in human skin. J Invest Dermatol 52 : 287-290, 1969
 
4) McKee PH, Calonge E, Granter SR : Pathology of the Skin with Clinical Correlations, 3rd ed. Elsevier Mosby, London, 2005
 
5) Mooi WJ, Krausz T (eds) : Pathology of Melanocytic Disorders, 2nd ed. Hodder Arnold, New York, 2007, pp134-136
 
6) Cochran AJ, Bailly C, Paul E et al (eds) : Melanocytic Tumors : A Guide to Diagnosis. Lippincott/Raven, Philadelphia, 1997, p34
 
7) Ackerman AB, Cerroni L, Kerl H : Pitfalls in Histopathologic Diagnosis of Malignant Melanoma. Lea & Febiger, Philadelphia, 1994, pp5-45
 
8) Massi G, LeBoit PE (eds) : Histological Diagnosis of Nevi and Melanoma. Springer, Wurzburg, 2004, pp71-84
 
9) LeBoit PE, Burg G, Weedon D et al : World Health Organization Classification of Tumours. Pathology & Genetics ; Skin Tumours. IARC Press, Lyon, 2006
 
P.32 掲載の参考文献
1) Ackerman AB, Cerroni L, Kerl H : Pitfalls in Histopathologic Diagnosis of Malignant Melanoma. Lea & Febiger, Malvern, 1994, pp3-33
 
2) Kopf AW, Bart RS, Hennessey P : Congenital nevocytic nevi and malignant melanomas. J Am Acad Dermatol 1 : 123-130, 1979
PubMed
3) 青木見佳子 : 最新皮膚科学体系 11. 母斑・母斑症悪性黒色腫 (玉置邦彦総編集). 中山書店, 2002, pp50-55
 
4) Elder DE, Elenitsas R, Murphy GF et al : Lever's Histopathology of the Skin, 9th ed. Lippincott Williams & Wilkins, Philadelphia, 2005, pp715-803
 
5) 木村鉄宣 : 色素細胞母斑 (扁平母斑・青色母斑を含めて). MB Derma 134 : 9-16, 2007
 
6) Mckee PH, Calonje E, Granter SR : Pathology of the Skin with Clinical Correlations, 3rd ed. Elsevier Mosby, Philadelphia, 2005, pp1291-1296
 
7) LeBoit PE, Burg G, Weedon D et al (eds) : World Health Organization Classification of Tumors. Pathology and Genetics of Skin Tumors. IARC Press, Lyon, 2006, pp93-94
 
8) 斎田俊明 : 先天性色素細胞母斑とメラノーマ. 新村真人 (監) : メラノーマの病理組織診断-症例検討から学ぶ診断のポイント-. 文光堂, 2002, pp5-6
 
9) Barnhill RL : Pathology of Melanocytic Nevi and Malignant Melanoma. Butterworth-Heinemann, Boston, 1995, p65
 
10) Elder DE, Murphy GF : Melanocytic Tumors of the Skin. AFIP, Washington, 1991, pp70-78
 
11) レバヴー・アンドレ, 大原國章 : proliferative noduleを生じた巨大母斑 (先天性色素細胞母斑). Visual Dermatol 11 : 1170-1172, 2003
 
12) 渡辺晋一 : 最新皮膚科学大系 2. 皮膚科治療学 皮膚科救急 (玉置邦彦編). 中山書店, 2003, pp190-199
 
P.43 掲載の参考文献
1) LeBoit PE, Burg G, Weedon D et al (eds) : World Health Organization Classification of Tumours. Pathology and Genetics of Skin Tumours. IARC Press, Lyon, 2006, pp95-99
 
2) Massi G, LeBoit PE (eds) : Histological Diagnosis of Nevi and Melanoma. Springer, Darmstadt, 2004, pp443-449
 
3) Carney JA, Ferreiro JA : The epithelioid blue nevus. A multicentric familial tumor with important associations, including cardiac myxoma and psammomatous melanotic schwannoma. Am J Surg Pathol 20 : 259-272, 1996
PubMed
4) 木村鉄宣 : 色素細胞母斑 (扁平母斑・青色母斑を含めて). MB Derma 134 : 9-16, 2007
 
P.46 掲載の参考文献
1) Barnhill RL : Combined naevus. in LeBoit PE, Burg G, Weedon D et al (eds) : "World Health Organization Classification of Tumours. Pathology & Genetics, Skin Tumours". IARC Press, Lyon, 2006, pp100-102
 
2) McKee PH, Calonje E, Granter SR (eds) : Pathology of the Skin with Clinical Correlations, 3rd ed. Elsevier Mosby, Philadelphia, 2005, pp1242-1263
 
3) Weedon D : Skin Pathology, 2nd ed. Churchill Livingstone, London, 2005, p813
 
4) Scolyer RA, Zhuang L, Palmer AA et al : Combined naevus : a benign lesion frequently misdiagnosed both clinically and pathologically as melanoma. Pathology 36 : 419-427, 2004
PubMed
5) Palmedo G, Hantschke M, Rutten A et al : The T1796A mutation of the BRAF gene is absent in Spitz nevi. J Cutan Pathol 31 : 266-270, 2004
PubMed
6) 泉美貴 : みき先生の皮膚病理診断ABC (3) メラノサイト系病変. 秀潤社, 2009, pp78-79
 
P.48 掲載の参考文献
1) Kerl H, Massi D : Melanocytic macules, simple lentigo and lentiginous melanocytic naevus. in LeBoit PE, Burg G, Weedon D et al (eds) : "World Health Organization Classification of Tumours. Pathology & Genetics, Skin Tumours" IARC Press, Lyon, 2006, pp103-104
 
2) McKee PH, Calonje E, Granter SR (eds) : Pathology of the Skin with Clinical Correlations, 3rd ed. Elsevier Mosby, Philadelphia, 2005, pp1242-1263
 
3) Weedon D : Skin Pathology, 2nd ed. Churchill Livingstone, London, 2005, pp803-858
 
P.49 掲載の参考文献
1) Kerl H, Massi D : Melanocytic macules, simple lentigo and lentiginous melanocytic naevus. in LeBoit PE, Burg G, Weedon D et al (eds) : "World Health Organization Classification of Tumours. Pathology & Genetics, Skin Tumours" IARC Press, Lyon, 2006, pp103-104
 
2) McKee PH, Calonje E, Granter SR (eds) : Pathology of the Skin with Clinical Correlations, 3rd ed. Elsevier Mosby, Philadelphia, 2005, pp1242-1263
 
3) Weedon D : Skin Pathology, 2nd ed. Churchill Livingstone, London, 2005, p804
 
4) 斎田俊明 : 皮膚病理組織診断学入門, 改訂第2版. 南江堂, 2009, p126
 
5) 泉美貴 : みき先生の皮膚病理診断ABC (3) メラノサイト系病変. 秀潤社, 2009, pp24-25
 
P.53 掲載の参考文献
1) Clark WH Jr, Reimer RR, Greene M et al : Origin of familial malignant melanomas from heritable melanocytic lesions. The B-K mole syndrome. Arch Dermatol 114 : 732-738, 1978
 
2) Elder DE, Goldman LI, Goldman SC et al : Dysplastic nevus syndrome. Cancer 46 : 1787-1794, 1980
PubMed
3) Ackerman AB : What naevus is dysplastic, a syndrome, and the commonest precursor of malignant melanoma? A riddle and an answer. Histopathology 13 : 241-245, 1988
 
4) Ackerman AB, Magana-Garcia M : Naming acquired melanocytic nevi. Unna's, Miescher's, Spitz's, Clark's. Am J Dermatopathol 12 : 193-209, 1992
 
5) 木村鉄宣 : Clark母斑. 玉置邦彦 (編) : 最新皮膚科学大系 11 母斑・母斑症, 悪性黒色腫. 中山書店, 2002, pp43-46
 
6) 石原和之 : 悪性黒色腫の疫学と予後因子. 斎田俊明, 山本明央 (編) : 悪性黒色腫の診断・治療指針. 金原出版, 2001, pp19-20
 
P.57 掲載の参考文献
1) LeBoit PE, Burg G, Weedon D et al (eds) : World Health Organization Classification of Tumours. Pathology & Genetics of Skin Tumours. IARC, Lyon, 2006, pp110-112
 
2) McKee PH, Calonje E (eds) : Diagnostic Atlas of Melanocytic Pathology. Mosby, Elsevier, 2009, 46-50
 
3) Fallowfield ME, Collina G, Cook MG : Melanocytic lesions of the palm and sole. Histopathology 24 : 463-467, 1994
PubMed
4) Massi G, LeBoit PE (eds) : Histological Diagnosis of Nevi and Melanoma. Springer, Heidelberg, 2004, pp289-302
 
5) 斎田俊明 : 悪性黒色腫の病理組織診断 : 診断と鑑別のポイント 悪性黒色腫の病理組織診断に迷った時に, どこに注目して鑑別するか. 日皮会誌 116 : 2037-2040, 2006
 
6) Massi G, LeBoit PE (eds) : Histological Diagnosis of Nevi and Melanoma. Springer, Heidelberg, 2004, pp303-314
 
7) Meyerson LB : Peculiar papulosquamous eruption involving pigmented nevi. Arch Dermatol 103 : 510-512, 1971
PubMed
P.58 掲載の参考文献
1) Blessing K : Benign atypical naevi : diagnostic difficulties and continued controversy. Histopathology 34 : 189-198, 1999
PubMed
2) Park HK, Leonard DD, Arrington JH III, et al : Recurrent melanocytic nevi : clinical and histologic review of 175 cases. J Am Acad Dermatol 17 : 285-292, 1987
 
3) Hoang MP, Prieto VG, Burchette JL et al : Recurrent melanocytic nevus : a histologic and immunohistochemical evaluation. J Cutan Pathol 28 : 400-406, 2001
PubMed
4) Alanko T, Rosenberg M, Saksela O : FGF expression allows nevus cells to survive in three-dimensional collagen gel under conditions that induce apoptosis in normal human melanocytes. J Invest Dermatol 113 : 111-116, 1999
PubMed
P.64 掲載の参考文献
1) LeBoit PE, Burg G, Weedon D et al : World Health Organization Classification of Tumors. Pathology and Genetics. Skin Tumours. IARC Press, Lyon, 2006, pp114-116
 
2) Spitz S : Melanoma of childhood. Am J Pathol 24 : 591-609, 1948
PubMed
3) Kernen JA, Ackerman LV : Spindle cell nevi and epithelioid cell nevi (so-called juvenile melanomas) in children and adults. A clinicopathologic study of 27 cases. Cancer 13 : 612-625, 1960
PubMed
4) Weedon D, Little JH : Spindle and epithelioid cell nevi in children and adults. A review of 211 cases of the Spitz nevus. Cancer 40 : 217-225, 1977
PubMed
5) Paniago-Pereira C, Maize J, Ackerman A : Nevus oflarge spindle and/or epithelioid cells (Spitz' nevus). Arch Dermatol 114 : 1811-1823, 1978
PubMed
6) Barnhill RL, Flotte T, Fleischli M et al : Childhood melanoma and atypical Spitz-tumors. Cancer 76 : 1833-1845, 1995
PubMed
7) 真鍋俊明, 宮川文 : Spitz母斑とメラノーマ. 病理と臨床 25 : 1239-1251, 2007
Medical*Online
8) Walsh N, Crotty K, Palmer A et al : Spitz nevus versus spitzoid malignant melanoma : an evaluation of the current distinguishing histopathologic criteria. Hum Pathol 29 : 1105-1112, 1998
PubMed
9) Kamino H, Skelton H, Lupton G et al : Eosinophilic globules in Spitz's nevi. New findings and a diagnostic sign. Am J Surg Pathol 1 : 319-324, 1979
 
10) Howat AJ, Variend S : Lymphatic invasion in Spitz nevi. Am J Surg Pathol 9 : 125-128, 1985
PubMed
11) Harvell JD, Bastian BC, LeBoit PE : Persistent (recurrent) Spitz Nevi : A histopathologic, immunohistochemical, and molecular pathologic study of 22 cases. Am J Surg Pathol 26 : 654-661, 2002
 
12) Palazzo J, Duray PH : Typical, dysplastic, congenital, and Spitz nevi : a comparative immunohistochemical study. Hum Pathol 20 : 341-346, 1989
 
13) Bergman R, Dromi R, Trau H et al : The pattern of HMB-45 antibody staining in compound Spitz nevi. Am J Dermatopathol 17 : 542-546, 1995
PubMed
14) Smith KJ, Barrett TL, Skelton HG III et al : Spindle cell and epithelioid cell nevi with atypia and metastasis (malignant Spitz nevus). Am J Surg Pathol 13 : 931-939, 1989
 
15) King R, Googe PB, Weilbaecher KN et al : Microphthalmia transcription factor expression in cutaneous benign, malignant melanocytic, and nonmelanocytic tumors. Am J Surg Pathol 25 : 51-57, 2001
PubMed
16) Nagasaka T, Lai R, Medeiros LJ et al : Cyclin D1 overexpression in Spitz nevi : an immunohistochemical study. Am J Dermatopathol 21 : 115-120, 1999
PubMed
17) Kanter-Lewensohn L, Hedblad MA, Wejde J et al : Immunohistochemical markers for distinguishing Spitz nevi from malignant melanomas. Mod Pathol 10 : 917-920, 1997
PubMed
18) Li LX, Crotty KA, McCarthy SW et al : A zonal comparison of MIB1-Ki67 immunoreactivity in benign and malignant melanocytic lesions. Am J Dermatopathol 22 : 489-495, 2000
PubMed
19) Bergman R, Malkin L, Sabo E et al : MIB-1 monoclonal antibody to determine proliferative activity of Ki-67 antigen as an adjunct to the histopathologic differential diagnosis of Spitz nevi. J Am Acad Dermatol 44 : 500-504, 2001
 
20) Kapur P, Selim MA, Roy LC et al : Spitz nevi and atypical Spitz nevi/tumors : a histologic and immunohistochemical analysis. Mod Pathol 18 : 197-204, 2005
PubMed
21) Vollmer RT : Use of Bayes rule and MIB-1 proliferation index to discriminate Spitz nevus from malignant melanoma. Am J Clin Pathol 122 : 499-505, 2004
PubMed
22) Bastian BC, LeBoit PE, Pinkel D : Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am J Pathol 157 : 967-972, 2000
PubMed
23) van Dijk MC, Bernsen MR, Ruiter DJ : Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma. Am J Surg Pathol 29 : 1145-1151, 2005
 
24) Barnhill RL : The Spitzoid lesion : rethinking Spitz tumors, atypical variants,' Spitzoid melanoma' and risk assessment. Mod Pathol 19 Suppl 2 : S21-S33, 2006
 
25) Spatz A, Calonje E, Handfield-Jones S et al : Spitz tumors in children : a grading system for risk stratification. Arch Dermatol 135 : 282-285, 1999
PubMed
26) Mones JM, Ackerman AB : "Atypical" Spitz's nevus, "malignant" Spitz's nevus, and "metastasizing" Spitz's nevus : a critique in historical perspective of three concepts flawed fatally. Am J Dermatopathol 26 : 310-333, 2004
 
P.66 掲載の参考文献
1) LeBoit PE, Burg G, Weedon D et al (eds) : World Health Organization Classification of Tumours. Pathology & Genetics of Skin Tumours. IARC Press, Lyon, 2006
 
2) Elder DE : Lever's Histopathology of the Skin, 10th ed. Lippincott Williams & Wilkins, Philadelphia, 2009
 
3) Weedon D : Weedon's Skin Pathology, 3rd ed. Elsevier, Amsterdam, 2010
 
4) Massi G, LeBoit PE : Histological Diagnosis of Nevi and Melanoma. Springer, Steinkopff Verlag, Darmstadt, 2004
 
P.69 掲載の参考文献
1) LeBoit PE, Burg G, Weedon D et al (eds) : World Health Organization Classification of Tumours. Pathology & Genetics of Skin Tumours. IARC Press, Lyon, 2006
 
2) Elder DE : Lever's Histopathology of the Skin, 10th ed. Lippincott Williams & Wilkins, Philadelphia, 2009
 
3) Weedon D : Weedon's Skin Pathology, 3rd ed. Elsevier, Amsterdam, 2010
 
4) Massi G, LeBoit PE : Histological Diagnosis of Nevi and Melanoma. Springer, Steinkopff Verlag, Darmstadt, 2004
 
P.86 掲載の参考文献
1) Guerry D IV, Synnestvedt M, Elder DE et al : Lessons from tumor progression : The invasive radial growth phase melanoma is common, incapable of metastasis, and indolent. J Invest Dermatol 100 : S342-S345, 1993
 
2) AJCC : Cancer Staging Manual, 7th ed. Springer-Verlag, New York, 2010 pp325-344
 
3) Muhlbauer JE, Margolis RJ, Mihm, MC Jr et al : Minimal deviation melanoma : a histological variant of cutaneous melanoma in its vertical growth phase. J Invest Dermatol 80 : 635-655, 1983
 
4) Philips ME, Margolis RJ, Merot Y et al : The spectrum of minimal deviation melanoma : a clinicopathological study of 21 cases. Hum Pathol 17 : 796-806, 1986
 
5) Schneiderman H, Yu-Yuan A, Campbell WA et al : Congenital melanoma with multiple prenatal metastases. Cancer 60 : 1371-1377, 1987
 
6) Reintgen DS, Vollmer R, Seigler HF : Juvenile malignant melanoma. Surg Gynecol Obstetr 168 : 249-253, 1989
 
7) Parkin DM, Bray F, Ferlay J et al : Global cancer statistics, 2002. CA Cacer J Cline 55 : 74-108, 2005
 
8) 石原和之 : 悪性黒色腫の疫学と予後因子. 斎田俊明, 山本明史 (編) : 悪性黒色腫の診断と治療. 金原出版, 2001, p12
 
9) Stewart BW, Kleihues P (eds) : WHO World Cancer Report. IARC Press, Lyon 2003, pp253-256
 
10) LeBoit PE, Burg G, Weedon D et al : WHO Classification of Tumours. Pathology & Genetics of Skin Tumors. IARC Press, Lyon, 2006, pp49-92
 
11) Maize JC, Ackerman AB : Pigmented Lesions of the Skin. Lea & Febiger, Philadelphia, 1987, pp165-269
 
12) Ishihara Y, Saida T, Miyoshi A et al : Early acral melanoma in situ. Correlation between the parallel ridge pattern on dermoscopy and microscopic features. Am J Dermatopathol 28 : 21-27, 2006
 
P.90 掲載の参考文献
1) Ishihara K, Saida T, Yamamoto A (Japanese Skin Cancer Society Prognosis and Statistical Investigation Committee) : Updated statistical data for malignant melanoma in Japan. Int J Clin Oncol 6 : 109-116, 2001
PubMed
2) Greene MH, Clark WH Jr, Tucker MA et al : High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. Ann Intern Med 102 : 458-465, 1985
PubMed
3) Clark WH Jr, Elder DE, Guerry D IV et al : A study of tumor progression : the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol 15 : 1147-1165, 1984
 
4) McGovern VJ, Shaw HM, Milton GW : Histogenesis of malignant melanoma with an adjacent component of the superficial spreading type. Pathology 17 : 251-254, 1985
PubMed
5) 泉美貴 : みき先生の皮膚病理診断ABC (3) メラノサイト系病変. 秀潤社, 2009, pp116-120
 
6) Stern JB, Haupt HM : Pagetoid melanocytosis : tease or tocsin? Semin Diagn Pathol 15 : 225-229, 1998
PubMed
7) McGovern VJ, Shaw HM, Milton GW : Histogenesis of malignant melanoma with an adjacent component of the superficial spreading type. Pathology 17 : 251-254, 1985
PubMed
8) Emanuel PO, Mannion M, Phelps RG : Complete regression of primary malignant melanoma. Am J Dermatopathol 30 : 178-181, 2008
PubMed
9) 高田実 : メラノーマ研究の最近の進歩. 信州医学雑誌 55 : 3-9, 2007
Medical*Online
P.93 掲載の参考文献
1) Ishihara K, Saida T, Otsuka F et al : Statistical profiles of malignant melanoma and other skin cancers in Japan : 2007 update. Int J Clin Oncol 13 : 33-41, 2008
PubMed
2) Kelly JW, Chamberlain AJ, Staples MP et al : Nodular melanoma. No longer as simple as ABC. Aust Fam Physician 32 : 706-709, 2003
PubMed
3) 泉美貴 : みき先生の皮膚病理診断ABC (3) メラノサイト系病変. 秀潤社, 2009, pp114-115
 
P.96 掲載の参考文献
1) Ishihara K, Saida T, Yamamoto A : Updated statistical data for malignant melanoma in Japan. Int J Clin Oncol 6 : 109-116, 2001
PubMed
2) Weinstock MA, Sober AJ : The risk of progression of lentigo maligna to lentigo maligna melanoma. Br J Dermatol 116 : 303-310, 1987
PubMed
3) Ishihara K, Saida T, Otsuka F et al : Statistical profiles of malignant melanoma and other skin cancers in Japan : 2007 update. Int J Clin Oncol 13 : 33-41, 2008
PubMed
4) 泉美貴 : みき先生の皮膚病理診断ABC (3) メラノサイト系病変. 秀潤社, 2009, pp112-113
 
P.100 掲載の参考文献
1) Reed RJ : Acral lentiginous melanoma. in Harmann W, Kay S, Reed RJ (eds) : New Concepts in Surgical Pathology of the Skin. John Wiley & Sons, New York, 1976, pp89-90
 
2) Kato T, Kumasaka N, Suetake T et al : Clinicopathological study of acral melanoma in situ in 44 Japanese patients. Dermatology 193 : 192-197, 1996
PubMed
3) Seiji M, Takematsu H, Hosokawa M et al : Acral melanoma in Japan. J Invest Dermatol 80 (Suppl) : S56-S60, 1983
 
4) 大原國章 : 小児の爪甲色素線条. 玉置邦彦 (編) : 最新皮膚科学大系, 特別巻 1 新生児・小児, 高齢者の皮膚疾患. 中山書店, 2004, pp190-194
 
5) Saida T, Miyazaki A, Oguchi S et al : Significance of dermoscopic patterns in detecting malignant melanoma on acral volar skin : results of a multicenter study in Japan. Arch Dermatol 140 : 1233-1238, 2004
PubMed
6) 泉美貴 : みき先生の皮膚病理診断ABC (3) メラノサイト系病変. 秀潤社, 2009, pp30-32, pp122-127
 
7) Nogita T, Wong TY, Ohara K et al : Atypical melanosis of the foot. A report of three cases in Japanese populations. Arch Dermatol 130 : 1042-1045, 1994
PubMed
8) Izumi M, Ohara K, Hoashi T et al : Subungual melanoma : histological examination of 50 cases from early stage to bone invasion. J Dermatol 35 : 695-703, 2008
PubMed
9) Signoretti S, Annessi G, Puddu P et al : Melanocytic nevi of palms and soles : a histological study according to the plane of section. Am J Surg Pathol 23 : 283-287, 1999
 
10) Tosti A, Baran R, Piraccini BM et al : Nail matrix nevi : a clinical and histopathological study of 22 patients. J Am Acad Dermatol 34 : 765-771, 1996
 
P.103 掲載の参考文献
1) Conley J, Lattes R, Orr W : Desmoplastic malignant melanoma (a rare variant of spindle cell melanoma). Cancer 28 : 914-936, 1971
PubMed
2) Reed RJ, Leonard DD : Neurotropic melanoma. A variant of desmoplastic melanoma. Am J Surg Pathol 3 : 301-311, 1979
PubMed
3) Wharton JM, Carlson JA, Mihm MC Jr : Desmoplastic malignant melanoma : diagnosis of early clinical lesions. Hum Pathol 30 : 537-542, 1999
PubMed
4) McCathy SW, Critty KA, Scolyer RA : Desmoplastic melanoma and desmoplastic neurotropic melanoma. in LeBoit PE, Burg G, Weedon D et al (eds) : "Pathology and Genetics of Skin Tumours". IARC Press, Lyon, 2006, pp76-78
 
5) de Almeida LS, Requena L, Rutten A et al : Desmoplastic malignant melanoma : a clinicopathologic analysis of 113 cases. Am J Dermatopathol 30 : 207-215, 2008
PubMed
6) Busam KJ : Cutaneous desmoplastic melanoma. Adv Anat Pathol 12 : 92-102, 2005
PubMed
7) Quinn MJ, Crotty KA, Thompson JF et al : Desmoplastic and desmoplastic neurotropic melanoma : experience with 280 patients. Cancer 83 : 1128-1135, 1998
PubMed
8) Busam KJ, Mujumdar U, Hummer AJ et al : Cutaneous desmoplastic melanoma : reappraisal of morphologic heterogeneity and prognostic factors. Am J Surg Pathol 28 : 1518-1525, 2004
PubMed
9) Shimada S, Tsuzuki T, Kuroda M et al : Nestin expression as a new marker in malignant peripheral nerve sheath tumors. Pathol Int 57 : 60-67, 2007
PubMed
P.106 掲載の参考文献
1) Connelly J, Smith JL Jr : Malignant blue nevus. Cancer 67 : 2653-2657, 1991
PubMed
2) Allen AC, Spitz S : Malignant melanoma : a clinicopathological analysis of the criteria for diagnosis and prognosis. Cancer 6 : 1-45, 1953
PubMed
3) Mones JM, Ackerman AB : "Atypical" blue nevus, "malignant" blue nevus, and "metastasizing" blue nevus : a critique in historical perspective of three concepts flawed fatally. Am J Dermatopathol 26 : 407-430, 2004
PubMed
4) Martin RC, Murali R, Scolyer RA et al : So-called "malignant blue nevus" : a clinicopathologic study of 23 patients. Cancer 115 : 2949-2955, 2009
PubMed
5) Requena L, Carlson JA : Melanoma arising from blue naevus. in LeBoit PE, Burg G, Weedon D et al (eds) : "Pathology and Genetics of Skin tumors". IARC Press, Lyon, 2006, pp79-82
 
6) Elder DE, Elenitsas R, Murphy GF et al : Lever's Histopathology of the Skin. Lippincott Williams & Wilkins, Philadelphia, 2009, pp772-774
 
7) Busam KJ : Metastatic melanoma to the skin simulating blue nevus. Am J Surg Pathol 23 : 276-282, 1999
 
8) Zembowicz A, Carney JA, Mihm MC : Pigmented epithelioid melanocytoma : a low-grade melanocytic tumor with metastatic potential indistinguishable from animal-type melanoma and epithelioid blue nevus. Am J Surg Pathol 28 : 31-40, 2004
PubMed
9) Zucman J, Delattre O, Desmaze C et al : EWS and ATF-1 gene fusion induced by t (12 ; 22) translocation in malignant melanoma of soft parts. Nat Genet 4 : 341-345, 1993
 
P.108 掲載の参考文献
1) Benisch B, Perison B, Kanneratein M, et al : Malignant melanoma originating from intradermal nevi. A clinicopathologic entity. Arch Dermatol 116 : 696-698, 1980
 
2) Kerl H, Clemente C, North PE : Melanoma arising in giant congenital naevi. in LeBoit PE, Burg G, Weedon D et al (eds) : "World Health Organization Classification of Tumours. Pathology and Genetics of Skin Tumours". IARC Press, Lyon, 2006, pp83-84
 
3) Chung C, Forte AJ, Narayan D, et al : Giant nevi : a review. J Craniofac Surg 17 : 1210-1215, 2006
 
4) Massi G, LeBoit PE : Histological Diagnosis of Nevi and Melanoma. Steinkopff Verlag, Darmstadt, 2004, pp551-564
 
P.110 掲載の参考文献
1) Davidoff AM, Cirrincione C, Seigler HF : Malignant melanoma in childhood. Ann Surg Oncol 1 : 278-282, 1994
 
2) Boddie AW Jr, Smith JL Jr, McBride CM : Malignant melanoma in children and young adults : effect of diagnostic criteria on staging and end results. South Med J 71 : 1074-1078, 1978
 
3) Bader JL, Li FP, Olmstead PM et al : Childhood malignant melanoma. Incidence and etiology. Am J Pediatr Hematol Oncol 7 : 341-345, 1985
PubMed
4) 山本明史, 山崎直也, 田口理史他 : 小児の悪性黒色腫. Skin Cancer 11 : 184-188, 1996
 
5) Barnhill RL. Childhood melanoma. in LeBoit PE, Burg G, Weedon D et al (eds) : "World Health Organization Classification of Tumours. Pathology and Genetics of Skin Tumours". IARC Press, Lyon, 2006, pp84-85
 
6) Jen M, Murphy M, Grant-Keis JM : Childhood melanoma. Clin Dermatol 27 : 529-536, 2009
 
7) Benisch B, Perison B, Kanneratein M et al : Malignant melanoma originating from intradermal nevi. A clinicopathologic entity. Arch Dermatol 116 : 696-698, 1980
 
8) Massi G, LeBoit PE : Histological Diagnosis of Nevi and Melanoma. Steinkopff Verlag, Darmstadt, 2004
 
P.112 掲載の参考文献
1) Massi G, LeBoit PE : Histological Diagnosis of Nevi and Melanoma. Steinkopff Verlag, Darmstadt, 2004.
 
2) McNutt NS, Kossard S : Naevoid melanoma. in LeBoit PE, Burg G, Weedon D et al (eds) : "World Health Organization Classification of Tumours. Pathology and Genetics of Skin Tumours". IARC Press, Lyon, 2006, pp86-89
 
P.115 掲載の参考文献
1) Heenan PJ, Maize JC, Cook MG et al : Persistent melanoma and local metastasis of melanoma. in LeBoit PE, Burg G, Weedon D et al (eds) : "World Health Organization Classification of Tumours. Pathology and Genetics of Skin Tumours". IARC Press, Lyon, 2006, pp90-92
 
2) Elder DE, Murphy GF : Melanocytic Tumors of the Skin. Armed Forces Institute of Pathology, Washington, D.C., 1991, pp196-199
 
3) Elder DE, Guerry D IV, Heiberger RM et al : Optimal resection margin for cutaneous malignant melanoma. Plast Reconstr Surg 71 : 66-72, 1983
 
4) Harrist TJ, Rigel DS, Day CL et al : "Microscopic satellites" are more highly associated with regional lymph node metastases than is primary melanoma thickness. Cancer 53 : 2183-2187, 1984
PubMed
5) Shekhel T, Glick RM, Crammer LD : In-transit metastasis from melanoma presenting as lymphangiectasis : a case report. Cutis 84 : 151-158, 2009
 
P.118 掲載の参考文献
1) Anandasabapathy N, Pulitzer M, Epstein W et al : Pseudolymphoma evolving into diffuse large B-cell lymphoma. Dermatol Online J 14 : 22, 2008
 
2) 長谷哲男, 佐藤かすみ, 宮沢めぐみ : 皮膚T細胞性偽リンパ腫. 玉置邦彦 (編) : 最新皮膚科学大系 13 神経系腫瘍, 間葉系腫瘍. 中山書店, 2002, pp302-303
 
3) Ackerman AB : If small plaque (digitate) parapsoriasis is cutaneous T-cell lymphoma, even an 'abortive' one, it must be mycosis fungoides! Arch Dermatol 132 : 562-566, 1996
PubMed
4) Levine PH, Jahan N, Murari P et al : Detection of human herpesvirus 6 in tissues involved by sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). J Infect Dis 166 : 291-295, 1992
PubMed
5) Chiou CC, Wang PN, Yang LC et al : Disseminated xanthogranulomas associated with adult T-cell leukemia/lymphoma : a case report and review the association of haematologic malignancies. J Eur Acad Dermatol Venereol 21 : 532-535, 2007
PubMed
6) Bang D, Cho NJ, Lee IJ et al : Appearance of Sezary-like atypical lymphocytes in the regressing lesions of juvenile xanthogranuloma. Its role in the spontaneous regression. Acta Derm Venereol 76 : 37-39, 1996
PubMed
P.122 掲載の参考文献
1) Arai E, Shimizu M, Hirose T : A review of 55 cases of cutaneous lymphoid hyperplasia : reassessment of the histopathologic findings leading to reclassification of 4 lesions as cutaneous marginal zone lymphoma and 19 pseudolymphomatous folliculitis. Hum Pathol 36 : 505-511, 2005
 
2) Arai E, Okubo H, Tsuchida T et al : Pseudolymphomatous folliculitis. A clinicopathologic entity of 15 cases of cutaneous pseudolymphoma with follicular invasion. Am J Surg Pathol 23 : 1313-1319, 1999
PubMed
3) Kerl H, Smolle J : Classification of cutaneous pseudolymphomas. Curr Probl Dermatol 19 : 167-175, 1990
 
4) Baldassano MF, Bailey EM, Ferry JA et al : Cutaneous lymphoid hyperplasia and cutaneus marginal zone lymphoma. Comparison of morphologic and immuno phenotypic features. Am J Surg Pathol 23 : 88-96, 1999
 
5) Kempf W, Dummer R, Burg G : Approach to lymphoproliferative infiltrates of the skin. The difficult lesions. Am J Clin Pathol 111 : S84-S93, 1999
PubMed
6) Toonstra J, Van der Putter SCJ, Van Wichen DF et al : Actinic reticuloid : immunohistochemical analysis of the cutaneous infiltrate in 13 patients. Br J Dermatol 120 : 779-786, 1989
 
7) Toussaint S, Kamino H : Noninfectious erythematous papular and squamous diseases. in Elder D, Elenitsas R, Jaworsky C et al (eds) : "Lever's Histopathology of the Skin, 8th ed". Lippincott-Raven, Philadelphia, 1997, pp151-184
 
P.125 掲載の参考文献
1) Brocq LAJ : Erythrodermie congenitale ichtyosiforme avec hyperepidermotrophie. Annales de Dermatologie et de Syphilographie III : 1-31, 1902
 
2) Simon M, Flaig MJ, Kind P et al : Large plaque parapsoriasis : clinical and genotypic correlations. J Cutan Pathol 27 : 57-60, 2000
PubMed
3) Haeffner AC, Smoller BR, Zepter K et al : Differentiation and clonality of lesional lymphocytes in small plaque parapsoriasis. Arch Dermatol 131 : 336-338, 1995
 
4) Pimpinelli M, Olsen EA, Santucci M et al : Defining early mycosis fungoides. J Am Acad Dermatol 53 : 1053-1063, 2005
 
5) Belousova IE, Vanecek T, Samtsov AV et al : A patient with clinicopathologic features of small plaque parapsoriasis presenting later with plaque stage mycosis fungoides : report of a case and comparative retrospective study of 27 cases of "nonprogressive" small plaque parapsoriasis. J Am Acad Dermatol 59 : 474-482, 2008
PubMed
6) Ackerman AB : If small plaque (digitate) parapsoriasis is cutaneous T-cell lymphoma, even an 'abortive' one, it must be mycosis fungoides! Arch Dermatol 132 : 562-566, 1996
PubMed
P.127 掲載の参考文献
1) Lau SK, Chu PG, Weiss LM : Immunohistochemical expression of langerin in Langerhans cell histiocytosis and non-Langerhans cell histiocytic disorders. Am J Surg Pathol 32 : 615-619, 2008
PubMed
2) Pileri SA, Grogan TM, Harris NL et al : Tumours of histiocytes and accessory dendritic cells : an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology 41 : 1-29, 2002
 
P.128 掲載の参考文献
1) Rezk SA, Spagnolo DV, Brynes RK et al : Indeterminate cell tumor. A rare dendritic neoplasm. Am J Surg Pathol 32 : 1868-1876, 2008
PubMed
2) Manente L, Cotellessa C, Schmitt I et al : Indeterminate cell histiocytosis : a rare histiocytic disorder. Am J Dermatopathol 19 : 276-283, 1997
 
3) Flores-Stadler ME, Gonzalez-Crussi F, Greene M et al : Indeterminate-cell histiocytosis : immunophenotypic and cytogenetic findings in an infant. Med Pediatr Oncol 32 : 250-254, 1999
 
P.130 掲載の参考文献
1) Kong Y, Kong J, Shi D et al : Cutaneous Rosai-Dorfman disease. A clinical and histopathologic study of 25 cases in China. Am J Surg Pathol 31 : 341-350, 2007
PubMed
2) Foucar E, Rosai J, Dorfman RF et al : Sinus histiocytosis with massive lymphadenopathy. An analysis of 14 deaths occurring in a patient registry. Cancer 54 : 1834-1840, 1984
 
P.132 掲載の参考文献
1) Kraus MD, Haley JC, Ruiz R et al : "Juvenile" xanthogranuloma. An immunophenotypic study with a reappraisal of histogenesis. Am J Dermatopathol 23 : 104-111, 2001
PubMed
2) Dehner LP : Juvenile xanthogranulomas in the first two decades of life. A clinicopathologic study of 174 cases with cutaneous and extracutaneous manifestations. Am J Surg Pathol 27 : 579-593, 2003
PubMed
P.134 掲載の参考文献
1) Miettinen M, Fetsch JF : Reticulohistiocytoma (solitary epithelioid histiocytoma). A clinicopathologic and immunohistochemical study of 44 cases. Am J Surg Pathol 30 : 521-528, 2006
PubMed
P.136 掲載の参考文献
1) 上出康二 : Congenital self-healing reticulohistiocytosis. 玉木邦彦 (編) : 最新皮膚科学大系 13 神経系腫瘍, 間葉系腫瘍, 中山書店, 2002, pp241-243
 
2) Hashimoto K, Bale GF, Hawkins HK et al : Congenital self-healing reticulohistiocytosis (Hashimoto-Pritzker type). Int J Dermatol 25 : 516-523, 1986
PubMed
3) Geissmann F, Lepelletier Y, Fraitag S et al : Differentiation of Langerhans cells in Langerhans cell histiocytosis. Blood 97 : 1241-1248, 2001
PubMed
4) Schaumburg-Lever G, Rechowicz E, Fehrenbacher B, et al : Congenital self-healing reticulohistiocytosis-a benign Langerhans cell disease. J Cutan Pathol 21 : 59-66, 1994
PubMed
5) Longaker MA, Frieden IJ, LeBoit PE et al : Congenital "self-healing" Langerhans cell histiocytosis : the need for long-term follow-up. J Am Acad Dermatol 31 : 910-916, 1994
PubMed
P.139 掲載の参考文献
1) Horny H-P, Metcalfe DD, Bennett JM et al : Mastocytosis. in Swerdlow SH, Campo E, Harris NL et al (eds) : "WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues", 4th ed, IARC Press, Lyon, 2008, pp54-63
 
2) Nettleship E, Tay W : Rare forms of urticaria. Br Med J 2 : 323-324, 1869
 
3) Horny H-P, Sotlar K, Valent P : Mastocytosis : State of the Art. Pathobiology 74 : 121-132, 2007
PubMed
4) 出光俊郎, 井上多恵 : 肥満細胞症 (肥満細胞腫). 玉木邦彦 (編) : 最新皮膚科学大系 13 神経系腫瘍, 間葉系腫瘍. 中山書店, 2002, pp341-354
 
5) Sweet WL, Smoller BR : Perivascular mast cells in urticaria pigmentosa. J Cutan Pathol 23 : 247-253, 1996
PubMed
6) Horny HP, Sillaber C, Menke D et al : Diagnostic value of immunostaining for tryptase in patients with mastocytosis. Am J Surg Pathol 22 : 1132-1140, 1998
PubMed
7) Li CY : Diagnosis of mastocytosis : value of cytochemistry and immunohistochemistry. Leuk Res 25 : 537-541, 2001
PubMed
8) Longley BJ, Tyrrell L, Lu SZ et al : Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis : establishment of clonality in a human mast cell neoplasm. Nat Genet 12 : 312-314, 1996
 
9) Nagata H, Okada T, Worobec AS et al : c-kit mutation in a population of patients with mastocytosis. Int Arch Allergy Immunol 113 : 184-186, 1997
 
10) Beghini A, Tibiletti MG, Roversi G et al : Germline mutation in the juxtamembrane domain of the kit gene in a family with gastrointestinal stromal tumors and urticaria pigmentosa. Cancer 92 : 657-662, 2001
 
P.144 掲載の参考文献
1) Willemze R, Jaffe ES, Burg G et al : WHO-EORTC classification for cutaneous lymphomas. Blood 105 : 3768-3785, 2005
PubMed
2) Swerdlow SH, Campo E, Harris NL et al (eds) : WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, 2008
 
3) Jaffe ES, Harris NL, Stein H et al (eds) : World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, 2001
 
4) Willemze R, Kerl H, Sterry W et al : EORTC classification for primary cutaneous lymphomas : A proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 90 : 354-371, 1997
 
5) Yamaguchi T, Ohshima K, Karube K et al : Clinicopathological features of cutaneous lesions of adult T-cell leukaemia/lymphoma. Br J Dermatol 152 : 76-81, 2005
PubMed
6) Yoshino T, Nakamura S, Suzumiya J et al : Expression of cutaneous lymphocyte antigen is associated with a poor outcome of nasal-type natural killer-cell lymphoma. Br J Haematol 118 : 482-487, 2002
PubMed
7) Yamaguchi M, Suzuki R, Kwong Yl et al : Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK) /T cell lymphoma and leukemia. Cancer Sci 99 : 1016-1020, 2008
PubMed
8) Hagiwara M, Takata K, Shimoyama Y et al : Primary cutaneous T-cell lymphoma of unspecified type with cytotoxic phenotype : clinicopathological analysis of 27 patients. Cancer Sci 100 : 33-41, 2009
PubMed
9) Ponzoni M, Ferreri AJ, Campo E et al : Definition, diagnosis, and management of intravascular large B-cell lymphoma : proposals and perspectives from an international consensus meeting. J Clin Oncol 25 : 3168-3173, 2007
 
10) Murase T, Yamaguchi M, Suzuki R et al : Intravascular large B-cell lymphoma (IVLBCL) : a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5. Blood 109 : 478-485, 2007
 
11) Oyama T, Yamamoto K, Asano N et al : Age-related EBVassociated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group : a study of 96 patients. Clin Cancer Res 13 : 5124-5132, 2007
 
12) Yamaguchi M, Nakamura N, Suzuki R et al : De novo CD5+ diffuse large B-cell lymphoma : results of a detailed clinicopathological review in 120 patients. Haematologica 93 : 1195-1202, 2008
PubMed
13) Kimura H, Morishima T, Kanegane H et al : Prognostic factors for chronic active Epstein-Barr virus infection. J Infect Dis 187 : 527-533, 2003
PubMed
14) Ohshima K, Kimura H, Yoshino T et al : CAEBV Study Group. Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults : overlap with chronic active EBV infection and infantile fulminant EBV T-LPD. Pathol Int 58 : 209-217, 2008
 
P.152 掲載の参考文献
1) Howard MS, Smoller BR : Mycosis fungoides : classic disease and valiant presentations. Semin Cutan Med Surg 19 : 91-99, 2000
 
2) Swerdlow SH, Campo E, Harris NL et al (eds) : World Health Organization Classification of Tumours. Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, 2008
 
3) Diamandidou E, Colome-Grimmer M, Fayad L et al : Transformation of mycosis fungoides/Sezary syndrome : Clinical characteristics and prognosis. Blood 92 : 1150-1159, 1998
PubMed
4) Woringer FR, Kolopp P : Lesion erythemato-squameuse polycyclique de l'vant -bras evoluant depuis 6 ans chez un garconnet de 13 ans. Ann Dermatol Venereol 10 : 945-948, 1939
 
5) Ketron LW, Goodman MH : Multiple lesions of the skin apparently of epithelial origin resembling clinically mycosis fungoides : report of a case. Arch Dermatol Syphil 24 : 758-777, 1931
 
6) Yagi H, Hagiwara T, Shirahama S et al : Disseminated pagetoid reticulosis : need for long-term follow-up. J Am Acad Dermatol 30 : 345-349, 1994
PubMed
7) Burns MK, Chan LS, Cooper KD : Woringer-Kolopp disease (localized pagetoid reticulosis) or unilesional mycosis fungoides? An analysis of eight cases with benign disease. Arch Dermatol 131 : 325-329, 1995
PubMed
8) Kim SY : Follicular mycosis fungoides. Am J Dermatopathol 7 : 300-301, 1985
PubMed
9) Lacour JP, Castanet J, Perrin C et al : Follicular mycosis fungoides. A clinical and histologic variant of cutaneous T cell lymphoma : report of two cases. J Am Acad Dermatol 29 : 330-334, 1993
 
10) Pereyo NG, Requena L, Galloway J et al : Follicular mycosis fungoides : a clinicopathologic study. J Am Acad Dermatol 36 : 563-568, 1997
 
11) Agar N, Whittaker SJ : Folliculotropic mycosis fungoides (stage IIA) progressing to Sezary syndrome : a case report. Br J Dermatol 159 : 1197-1199, 2008
PubMed
P.154 掲載の参考文献
1) Sezary A, Bouvrain Y : Erythrodermie avec presence de cellules monstrueuses dans le derme et le sang circulant. Bull Soc Fr Dermatol Syphiligr 45 : 254-260, 1938
 
2) Vonderheid EC, Bernengo MG, Burg G et al : Update on erythrodermic cutaneous T-cell lymphomas : report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol 46 : 95-106, 2002
PubMed
3) 長谷哲男 : 菌状息肉症/Sezary症候群の治療. 血液・腫瘍科 40 : 387-394, 2000
 
P.156 掲載の参考文献
1) Convit J, Kerdel F, Goihman M et al : Progressive, atrophying, chronic granulomatous dermohypodermitis. Autoimmune disease? Arch Dermatol 107 : 271-274, 1973
PubMed
2) Ackerman AB : Granulomatous slack skin. in "Histologic Diagnosis of Inflammatory Skin Diseases". Lea & Febiger, Philadelphia, pp483-485, 1978
 
3) van Haselen CW, Toonstra J, van der Putte SJ et al : Granulomatous slack skin. Report of three patients with an updated review of the literature. Dermatology 196 : 382-391, 1998
PubMed
4) Kavusi S, Nazemi MJ, Ghiasi M et al : Granulomatous slack skin. Dermatol Online J 12 : 20, 2010
 
5) Swerdlow SH, Campo E, Harris NL et al (eds) : World Health Organization Classification of Tumours. Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, 2008
 
6) Topar G, Zelger B, Schmuch M et al : Granulomatous slack skin : a distinct disorder or a variant of mycosis fungoides? Acta Derm Venereol 81 : 42-44, 2001
PubMed
7) Willemze R, Jaffe ES, Burg G et al : WHO-EORTC classification for cutaneous lymphomas. Blood 105 : 3768-3785, 2005
PubMed
P.161 掲載の参考文献
1) Willemze R, Jaffe ES, Burg G et al : WHO-EORTC classification for cutaneous lymphomas. Blood 105 : 3768-3785, 2005
PubMed
2) Lucioni M, Ippoliti G, Campana C et al : EBV positive primary cutaneous CD30+ large T-cell lymphoma in a heart transplanted patient : case report. Am J Transplant 4 : 1915-1920, 2004
 
3) Ralfkiaer E, Willemze R, Paulli M et al : Primary cutaneous CD30-positive T-cell lymphoproliferative disorders. in Sweerdlow SH, Campo E, Harris NL et al (eds) : "WHO Classification of Tumours. Haematopoietic and Lymphoid Tissues". IARC, Lyon, 2008, pp300-301
 
4) Martin JM, Ricart JM, Monteagudo C et al : Primary cutaneous CD30+ anaplastic large-cell lymphomas mimicking keratoacanthomas. Clin Exp Dermatol 32 : 668-671, 2007
PubMed
5) Kadin ME, Pinkus JL, Pinkus GS et al : Primary cutaneous ALCL with phosphorylated/activated cytoplasmic ALK and novel phenotype : EMA/MUC1+, cutaneous lymphocyte antigen negative. Am J Surg Pathol 32 : 1421-1426, 2008
PubMed
6) Bekkenk MW, Geelen FA, van Voorst Vader PC et al : Primary and secondary cutaneous CD30 (+) lymphoproliferative disorders : a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood 95 : 3653-3661, 2000
 
7) Kempf W, Willemze R, Jaffe ES et al : CD30+ T-cell lymphoproliferative disorders. in LeBoit PE, Burg G, Weedon D et al (eds) : World Health Organization Classification of Tumours. Pathology and Genetics of Skin Tumours. IARC, Lyon, 2006, pp179-181
 
P.164 掲載の参考文献
1) Jaffe ES, Gaulard P, Ralfkiaer E et al : Subcutaneous panniculitis-like T-cell lymphoma, in Sweerdlow SH, Campo E, Harris NL et al (eds) : WHO Classification of Tumours. Haematopoietic and Lymphoid Tissues, IARC, Lyon, 2008, pp294-295
 
2) Willemze R, Jansen PM, Cerroni L et al : Subcutaneous panniculitis-like T-cell lymphoma : definition, classification, and prognostic factors : an EORTC Cutaneous Lymphoma Group Study of 83 cases. Blood 111 : 838-845, 2008
 
3) 大塚幹夫 : 皮下脂肪織炎様T細胞リンパ腫とγδ (皮膚) T細胞リンパ腫. 瀧川雅浩, 岩月啓氏, 大島孝一他 (編) : 新・皮膚悪性リンパ腫アトラス. 文光堂, 2006, pp68-72
 
4) Parveen Z, Thompson K : Subcutaneous panniculitis-like T-cell lymphoma : redefinition of diagnostic criteria in the recent World Health Organization-European Organization for Research and Treatment of Cancer Classification for Cutaneous Lymphomas. Arch Pathol Lab Med 133 : 303-308, 2009
PubMed
P.173 掲載の参考文献
1) Aguilera P, Mascaro JM Jr, Martinez A et al : Cutaneous gamma/delta T-cell lymphoma : a histopathologic mimicker of lupus erythematosus profundus (lupus panniculitis). J Am Acad Dermatol 56 : 643-647, 2007
PubMed
2) Koch R, Jaffe ES, Mensing C et al : Cutaneous gamma/delta T-cell lymphoma. J Dtsch Dermatol Ges 7 : 1065-1067, 2009
PubMed
3) Willemze R, Jansen PM, Cerroni L et al (EORTC Cutaneous Lymphoma Group) : Subcutaneous panniculitis-like T-cell lymphoma : definition, classification, and prognostic factors : an EORTC Cutaneous Lymphoma Group Study of 83 cases. Blood 111 : 838-845, 2008
 
4) Toro JR, Liewehr DJ, Pabby N et al : Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma. Blood 101 : 3407-3412, 2003
PubMed
5) Gormley RH, Hess SD, Anand D et al : Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma. J Am Acad Dermatol 62 : 300-307, 2010
PubMed
6) Berti E, Tomasini D, Vermeer MH et al : Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior. Am J Pathol 155 : 483-492, 1999
PubMed
7) Santucci M, Pimpinelli N, Massi D et al : Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop. EORTC Cutaneous Lymphoma Task Force. Cancer 97 : 610-627, 2003
PubMed
8) Marzano AV, Ghislanzoni M, Gianelli U et al : Fatal CD8+ epidermotropic cytotoxic primary cutaneous T-cell lymphoma with multiorgan involvement. Dermatology 211 : 281-285, 2005
PubMed
9) Bekkenk MW, Vermeer MH, Jansen PM et al : Peripheral T-cell lymphomas unspecified presenting in the skin : analysis of prognostic factors in a group of 82 patients. Blood 102 : 2213-2219, 2003
 
10) Yoshizawa N, Yagi H, Horibe T et al : Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma with a CD15 (+) CD30 (-) phenotype. Eur J Dermatol 17 : 441-442, 2007
PubMed
11) Grogg KL, Jung S, Erickson LA et al : Primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma : a clonal T-cell lymphoproliferative disorder with indolent behavior. Mod Pathol 21 : 708-715, 2008
PubMed
12) Garcia-Herrera A, Colomo L, Camos M et al : Primary cutaneous small/medium CD4+ T-cell lymphomas : a heterogeneous group of tumors with different clinicopathologic features and outcome. J Clin Oncol 26 : 3364-3371, 2008
PubMed
13) Weaver J, Mahindra AK, Pohlman B et al : Non-mycosis fungoides cutaneous T-cell lymphoma : reclassification according to the WHO-EORTC classification. J Cutan Pathol 37 : 516-524, 2010
 
14) Rodriguez Pinilla SM, Roncador G, Rodriguez-Peralto JL et al : Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers. Am J Surg Pathol 33 : 81-90, 2009
PubMed
15) Blank C, Brown I, Marks R et al : Absence of programmed death receptor 1 alters thymic development and enhances generation of CD4/CD8 double-negative TCR-transgenic T cells. J Immunol 171 : 4574-4581, 2003
PubMed
16) Hagiwara M, Takata K, Shimoyama Y et al : Primary cutaneous T-cell lymphoma of unspecified type with cytotoxic phenotype : clinicopathological analysis of 27 patients. Cancer Sci 100 : 33-41, 2009
PubMed
17) Petrella T, Maubec E, Cornillet-Lefebvre P et al : Indolent CD8-positive lymphoid proliferation of the ear : a distinct primary cutaneous T-cell lymphoma? Am J Surg Pathol 31 : 1887-1892, 2007
 
18) Ryan AJ, Robson A, Hayes BD et al : Primary cutaneous peripheral T-cell lymphoma, unspecified with an indolent clinical course : a distinct peripheral T-cell lymphoma? Clin Exp Dermatol 35 : 892-896, 2010
PubMed
19) Khamaysi Z, Ben-Arieh Y, Epelbaum R et al : Pleomorphic CD8+ small/medium size cutaneous T-cell lymphoma. Am J Dermatopathol 28 : 434-437, 2006
PubMed
20) Beltraminelli H, Mullegger R, Cerroni L : Indolent CD8+ lymphoid proliferation of the ear : A phenotypic variant of the small-medium pleomorphic cutaneous T-cell lymphoma? J Cutan Pathol 37 : 81-84, 2010
 
21) Mattoch IW, Fulton R, Kim Y et al : Cutaneous peripheral T-cell lymphoma associated with a proliferation of B cells. Am J Clin Pathol 131 : 810-819, 2009
PubMed
P.178 掲載の参考文献
1) Shimoyama M (The Lymphoma Study Group) : Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. Br J Haematol 79 : 428-437, 1991
 
2) Setoyama M, Katahira Y, Kanzaki T : Clinicopathologic analysis of 124 cases of adult T-cell leukemia/lymphoma with cutaneous manifestations : the smouldering type with skin manifestations has a poorer prognosis than previously thought. J Dermatol 26 : 785-790, 1999
 
3) Johno M, Ohishi M, Kojo Y et al : Cutaneous manifestations of adult T-cell leukemia/lymphoma. Gann Monogr Cancer Res 39 : 33-42, 1992
 
4) Hamada T, Setoyama M, Katahira Y et al : Differences in HTLV-I integration patterns between skin lesions and peripheral blood lymphocytes of HTLV-I seropositive patients with cutaneous lymphoproliferative disorders. J Dermatol Sci 4 : 76-82, 1992
PubMed
5) Amano M, Kurokawa M, Ogata K et al : Cutaneous type adult T-cell leukemia/lymphoma. New entity and its definition and its diagnostic criteria : HTLV-I proviral DNA load can distinguish between cutaneous type ATLL and smoldering type ATLL. J Dermtol 35 : 270-275, 2008
PubMed
6) Bittencourt AL, Barbosa HS, Vieira MD et al : Adult T-cell leukemia/lymphoma (ATL) presenting in the skin : clinical, histological and immunohistochemical features of 52 cases. Acta Oncol 48 : 598-604, 2009
PubMed
7) Ohshima K : Pathological features of disease associated with human T-cell leukemia virus type I. Cancer Sci 98 : 772-778, 2007
PubMed
8) Yoshie O, Fujisawa R, Nakayama T et al : Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells. Blood 99 : 1505-1511, 2002
PubMed
9) Kakinuma T, Sugaya M, Nakamura K et al : Thymus and activation-regulated chemokine (TARC/CCL17) in mycosis fungoides : serum TARC levels reflect the disease activity of mycosis fungoides. J Am Acad Dermatol 48 : 23-30, 2003
PubMed
10) Ferenczi K, Fuhlbrigge RC, Pinkus J et al : Increased CCR4 expression in cutaneous T cell lymphoma. J Invest Dermatol 119 : 1405-1410, 2002
PubMed
11) Ishida T, Utsunomiya A, Iida S et al : Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma : its close association with skin involvement and unfavorable outcome. Clin Cancer Res 9 : 3625-3634, 2003
PubMed
12) 松岡雅雄 : HTLV-1による発癌機構. 渡邊俊樹, 上平憲, 山口一成 (編) : HTLV-1と疾患. 文光堂, 2007, pp191-193
 
13) Kohno T, Yamada Y, Akamatsu N et al : Possible origin of adult T-cell leukemia/lymphoma cells from human T lymphotropic virus type-1-infected regulatory T cells. Cancer Sci 96 : 527-533, 2005
PubMed
14) Toulza F, Nosaka K, Takiguchi M et al : FoxP3+ regulatory T cells are distinct from leukemia cells in HTLV-1-associated adult T-cell leukemia. Int J Cancer 125 : 2375-2382, 2009
PubMed
15) Tsukasaki K, Hermine O, Bazarbachi A et al : Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma : a proposal from an international consensus meeting. J Clin Oncol 27 : 453-459, 2009
PubMed
P.186 掲載の参考文献
1) Chan JK, Sin VC, Wong KF et al : Nonnasal lymphoma expressing the natural killer cell marker CD56 : a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 89 : 4501-4513, 1997
PubMed
2) Drenou B, Lamy T, Amiot L et al : CD3- CD56+ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance. Blood 89 : 2966-2974, 1997
PubMed
3) Mori N, Yatabe Y, Oka K et al : Expression of perforin in nasal lymphoma. Additional evidence of its natural killer cell derivation. Am J Pathol 149 : 699-705, 1996
PubMed
4) Wong KF, Zhang YM, Chan JK : Cytogenetic abnormalities in natural killer cell lymphoma/leukemia- is there a consistent pattern? Leuk Lymphoma 34 : 241-250, 1999
 
5) Raab-Traub N, Flynn K : The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47 : 883-889, 1986
PubMed
6) Swerdlow SH, Campo E, Harris NL et al (eds) : WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, 2008
 
7) Kimura H, Morishima T, Kanegane H et al : Prognostic factors for chronic active Epstein-Barr virus infection. J Infect Dis 187 : 527-533, 2003
PubMed
8) Suzuki K, Ohshima K, Karube K et al : Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults. Int J Oncol 24 : 1165-1174, 2004
 
9) Kawa K : Diagnosis and treatment of Epstein-Barr virusassociated natural killer cell lymphoproliferative disease. Int J Hematol 78 : 24-31, 2003
PubMed
10) 岩月啓氏 : EBウイルス関連T/NK細胞増殖疾患. 瀧川雅浩, 岩月啓氏, 大島孝一他 (編) : 新・皮膚悪性リンパ腫アトラス. 文光堂, 2006, pp94-99
 
11) Tokura Y, Ishihara S, Tagawa S et al : Hypersensitivity to mosquito bites as the primary clinical manifestation of a juvenile type of Epstein-Barr virus-associated natural killer cell leukemia/lymphoma. J Am Acad Dermatol 45 : 569-578, 2001
PubMed
P.191 掲載の参考文献
1) Swerdlow SH, Campo E, Harris NL et al (eds) : WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, 2008
 
2) 藤井一恭, 若月啓氏 : 皮膚外原発T細胞リンパ腫の皮膚浸潤. 瀧川雅浩, 岩月啓氏, 大島孝一他 (編) : 新・皮膚悪性リンパ腫アトラス, 文光堂, 2006, pp92-93
 
P.193 掲載の参考文献
1) Swerdlow SH, Campo E, Harris NL et al (eds) : WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, 2008, pp214-217
 
2) Willemze R, Jaffe ES, Burg G et al : WHO-EORTC classification for cutaneous lymphomas. Blood 105 : 3768-3785, 2005
PubMed
3) Takino H, Li C, Hu S et al : Primary cutaneous marginal zone B-cell lymphoma : a molecular and clinicopathological study of cases from Asia, Germany, and the United States. Mod Pathol 21 : 1517-1526, 2008
 
P.197 掲載の参考文献
1) Swerdlow SH, Campo E, Harris NL, et al (eds) : WHO Classification of Tumours. Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, 2008
 
2) Kodama K, Massone C, Chott A et al : Primary cutaneous large B cell lymphomas : clinicopathologic features, classification, and prognostic factors in a large series of patients. Blood 106 : 2491-2497, 2005
 
3) Senff NJ, Hoefnagel JJ, Jansen PM et al : Reclassification of 300 primary cutaneous B-cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas : comparison with previous classifications and identification of prognostic markers. J Clin Oncol 25 : 1581-1587, 2007
 
4) Zinzani PL, Quaglino P, Pimpineli N et al : Prognostic factors in primary cutaneous B-cell lymphoma : the Italian Study Group for Cutaneous Lymphomas. J Clin Oncol 24 : 1376-1382, 2006
 
5) Smith BD, Glusac EJ, McNiff JM et al : Primary cutaneous B-cell lymphoma treated with radiotherapy : a comparison of the European Organization for Research and Treatment of Cancer and the WHO classification systems. J Clin Oncol 22 : 634-639, 2004
PubMed
6) Coelho JD, Diamantino F, Costa I et al : Transformation of a cutaneous follicle center lymphoma to a diffuse large B cell lymphoma-an unusual presentation. Case Report Med 2010 ; Epub
 
7) Xie X, Sundram U, Natkuman Y et al : Expression of HGAL in primary cutaneous large B-cell lymphomas : evidence for germinal center derivation of primary cutaneous follicular lymphoma. Mod Pathol 21 : 653-659, 2008
 
8) Koens L, Vermeer MH, Willemze R et al : IgM expression of paraffin sections distinguishes primary cutaneous large B-cell lymphoma, leg type from primary cutaneous follicle center lymphoma. Am J Surg Pathol 7 : 1043-1048, 2010
 
9) Mirza I, Macpherson N, Paproski S et al : Primary cutaneous follicular lymphoma : an assessment of clinical, histopathologic, immunophenotypic, and molecular features. J Clin Oncol 20 : 647-655, 2002
PubMed
10) Perez M, Pacchiarotti A, Frontani M et al : Primary cutaneous B-cell lymphoma is associated with somatically hypermutated immunoglobulin variable genes and frequent use of VH1-69 and VH4-59 segments. Br J Dermato 162 : 611-618, 2010
 
P.201 掲載の参考文献
1) Willemze R, Jaffe ES, Burg G et al : WHO-EORTC classification for cutaneous lymphomas. Blood 105 : 3768-3785, 2005
PubMed
2) Swerdlow SH, Campo, E, Harris, NL et al (eds) : WHO Classification of Tumours. Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, 2008
 
3) Grange F, Beylot-Barry M, Courville P et al : Primary cutaneous diffuse large B-cell lymphoma, leg type ; clinicopathologic features and prognostic analysis in 60 cases. Arch Dermatol 143 : 1144-1150, 2007
PubMed
4) Li S, Griffin CA, Mann RB et al : Primary cutaneous T-cell-rich B-cell lymphoma : clinically distinct from its nodal counterpart? Mod Pathol 14 : 10-13, 2001
 
5) Oyama T, Yamamoto K, Asano N et al : Age-related EBVassociated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group : a study of 96 patients. Clin Cancer Res 13 : 5124-5132, 2007
 
6) Yamaguchi M, Nakamura N, Suzuki R et al : De novo CD5+ diffuse large B-cell lymphoma : results of a detailed clinicopathological review in 120 patients. Haematologica 93 : 1195-1202, 2008
PubMed
P.204 掲載の参考文献
1) Nakamura S, Ponzoni M, Campo E : Intravascular large B-cell lymphoma. in Swedlow SH, Campo E, Harris NL et al (eds) : "WHO Classification of Tumours. Haematopietic and Lymphoid Tissues". IARS Press, Lyon, 2008, pp252-253
 
2) Asada N, Odawara J, Kimura S et al : Use of random skin biopsy for diagnosis of intravascular large B-cell lymphoma. Mayo Clin Proc 82 : 1525-1527, 2007
 
3) Murase T, Yamaguchi M, Suzuki R et al : Intravascular large B-cell lymphoma (IVLBCL) : a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5. Blood 109 : 478-485, 2007
 
4) Murase T, Nakamura S, Kawauchi K et al : An Asian variant of intravascular large B-cell lymphoma : clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with haemophagocytic syndrome. Br J Haematol 111 : 826-834, 2000
 
5) Murase T, Nakamura S : An Asian variant of intravascular lymphomatosis : an updated review of malignant histiocytosis-like B-cell lymphoma. Leuk Lymphoma 33 : 459-473, 1999
 
6) Murase T, Nakamura S, Tashiro K et al : Malignant-histiocytosis-like B-cell lymphoma, a distinct pathologic variant of intravascular lymphomatosis : a report of five case and review of the literature. Br J Haematol 99 : 656-664, 1997
 
7) Ponzoni M, Ferreri AJ, Campo E et al : Definition, diagnosis, and management of intravascular large B-cell lymphoma : Proposals and perspectives from an International Consensus Meeting. J Clin Oncol 25 : 3168-3173, 2007
 
8) Yamaguchi M, Nakamura N, Suzuki R et al : De novo CD5+ diffuse large B-cell lymphoma : results of a detailed clinicopathological review in 120 patients. Haematologica 93 : 1195-1202, 2008
PubMed
9) Takahashi E, Kajimoto K, Fukatsu T et al : Intravascular large T-cell lymphoma : a case report of CD30-positive and ALK-negative anaplastic type with cytotoxic molecule expression. Virchows Arch 447 : 1000-1006, 2005
 
10) Shimada K, Matsue K, Yamamoto K et al : Retrospective analysis of intravascular large B-cell lymphoma treated with rituximab-containing chemotherapy as reported by the IVL study group in Japan. J Clin Oncol 26 : 3189-3195, 2008
 
P.209 掲載の参考文献
1) Pittaluga S, Wilson WH, Jaffe ES : Lymphomatoid granulomatosis. in Swedlow SH, Campo E, Harris NL et al (eds) : WHO Classification of Tumours of Haematopietic and Lymphoid Tissues. IARS Press, Lyon, 2008, pp247-249
 
2) Beaty MW, Toro J, Sorbara L et al : Cutaneous lymphomatoid granulomatosis : correlation of clinical and biologic features. Am J Surg Pathol 25 : 1111-1120, 2001
PubMed
3) Dojcinov SD, Venkataraman G, Raf feld M et al : EBV positive mucocutaneous ulcer-a study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol 34 : 405-417, 2010
 
4) Nakamura S, Jaffe ES, Swerdlow SH : EBV positive diffuse large B-cell lymphoma of the elderly. in Swedlow SH, Campo E, Harris NL et al (eds) : WHO Classification of Tumours of Haematopietic and Lymphoid Tissues. IARS Press, Lyon, 2008, pp243-244
 
5) Oyama T, Ichimura K, Suzuki R et al : Senile EBV+ B-cell lymphoproliferative disorders : a clinicopathologic study of 22 patients. Am J Surg Pathol 27 : 16-26, 2003
PubMed
6) Oyama T, Yamamoto K, Asano N et al : Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group : a study of 96 patients. Clin Cancer Res 13 : 5124-5132, 2007
 
7) Asano N, Yamamoto K, Tamaru JI et al : Age-related EBV-associated B-cell lymphoproliferative disorders : comparison with EBV-positive classical Hodgkin lymphoma in elderly patients. Blood 113 : 2629-2636, 2009
PubMed
P.210 掲載の参考文献
1) Yamaguchi M, Seto M, Okamoto M et al : De novo CD5+ diffuse large B-cell lymphoma : a clinicopathologic study of 109 patients. Blood 99 : 815-821, 2002
PubMed
P.212 掲載の参考文献
1) 田丸淳一 : 悪性リンパ腫 : 診断と治療の進歩. II. 診断へのアプローチ 1. 病理診断. 日内会誌 97 : 1537-1545, 2008
 
2) Tamaru J, Tokuhira M, Nittsu N et al : Hodgkin-like anaplastic large cell lymphoma (previously designated in the REAL classification) has same immunophenotypic features to classical Hodgkin lymphoma. Leuk Lymphoma 48 : 1127-1138, 2007
PubMed
3) Weedon D : Skin Pathology, 2nd ed. Churchill Livingstone, New York, 2002, pp1117-1118
 
4) McKee PH, Calonje E, Granter SR (eds) : Pathology of the Skin with Clinical Correlations, vol 2, 3rd ed. Elsevier Mosby 2005, pp1448-1450
 
P.216 掲載の参考文献
1) Katsuno M, Abe Y, Taguchi F et al : CD7+ stem cell leukemia/lymphoma. Features of a subgroup without circulating blast cells. Cancer 72 : 99-104, 1993
PubMed
2) Chaperot L, Bendriss N, Manches O et al : Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood 97 : 3210-3217, 2001
PubMed
3) Suzuki R, Yamamoto K, Seto M et al : CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia : a distinct hematolymphoid disease entity. Blood 90 : 2417-2428, 1997
PubMed
4) Chan JKC, Jaffe ES, Ralfkiaer E : Blastic NK-cell lymphoma. in Jaffe ES, Harris NL, Stein H et al (eds) : "WHO Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues". IARC Press, Lyon, 2001, pp214-215
 
5) Petrella T, Comeau MR, Maynadie M et al : Agranular CD4+ CD56+ hematodermic neoplasm (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes. Am J Surg Pathol 26 : 852-862, 2002
PubMed
6) Herling M, Teitell MA, Shen RR et al : TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin. Blood 101 : 5007-5009, 2003
PubMed
7) Herling M, Jones D : CD4+/CD56+ hematodermic tumor : the features of an evolving entity and its relationship to dendritic cells. Am J Clin Pathol 127 : 687-700, 2007
PubMed
8) Swerdlow SH, Campo E, Harris NL et al (eds) : WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, 2008
 
P.218 掲載の参考文献
1) Warnke RA, Weiss LM, Chan JKC et al : Atlas of Tumor Pathology. Tumors of the Lymph Nodes and Spleen. Armed Forces Institute of Pathology, Washington, D.C., 1995
 
2) Brunning RD, Borowitz M, Matutes E et al : Precursor T lymphoblastic leukemia/lymphoblastic lymphoma (precursor T-cell acute lymphoblastic leukaemia). in Jaffe ES, Harris NL, Stein H et al (eds) : "WHO Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues". IARC Press, Lyon 2001, pp115-117
 
3) Okuda T, Fisher R, Downing JR : Molecular diagnostics in pediatric acute lymphoblastic leukemia. Mol Diagn 1 : 139-151, 1996
PubMed
4) Swerdlow SH, Campo E, Harris NL et al (eds) : WHO Classification of Tumours. Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, 2008
 
P.221 掲載の参考文献
1) Grogan TM, Pileri SA, Chan JKC et al : Histiocytic sarcoma. in Swerdlow SH, Campto E, Harris NL, et al (eds) : "WHO Classification of Tumours. Haematopoietic and Lymphoid Tissues". IARC Press, Lyon, 2008, pp356-357
 
2) Hornick JL, Jaffe ES, Fletcher CD : Extranodal histiocytic sarcoma : clinicopathologic analysis of 14 cases of a rare epithelioid malignancy. Am J Surg Pathol 28 : 1133-1144, 2004
PubMed
3) Vos JA, Abbondanzo SL, Barekman CL et al : Histiocytic sarcoma : a study of five cases including the histiocytic marker CD163. Mod Pathol 18 : 693-704, 2005
PubMed
P.222 掲載の参考文献
1) Ratnum KV, Khor CJ, Su WP : Leukemia cutis. Dermatol Clin 12 : 419-431, 1994
 
2) Kaddu S, Zenahlik P, Beham-Schmid C et al : Specific cutaneous infiltrates in patients with myelogenous leukemia : a clinicopathologic study of 26 patients with assessment of diagnostic criteria. J Am Acad Dermatol 40 : 966-978, 1999
PubMed

第3部 鑑別ポイント

P.235 掲載の参考文献
1) Angelucci D, Natali PG, Amerio PL et al : Rapid perinatal growth mimicking malignant transformation in a giant congenital melanocytic nevus. Hum Pathol 22 : 297-301, 1991
 
2) Borbujo J, Jara M, Cortes L et al : A newborn with nodular ulcerated lesion on a giant congenital nevus. Pediatr Dermatol 17 : 299-301, 2000
 
3) 泉美貴 : みき先生の皮膚病理診断ABC (3) メラノサイト系病変. 秀潤社, 2009, pp88-90
 
P.237 掲載の参考文献
1) Meyerson LB : A peculiar papulosquamous eruption involving pigmented nevi. Arch Dermatol 103 : 510-512, 1971
PubMed
2) Nicholls DS, Mason GH : Halo dermatitis around a melanocytic naevus : Meyerson's naevus. Br J Dermatol 118 : 125-127, 1988
 
3) Candiago E, Marocolo D, Manganoni MA et al : Non-lymphoid intra-epidermal mononuclear cell collections (pseudo-Pautrier abscesses) : a morphologic and immunophenotypical characterization. Am J Dermatopathol 22 : 1-6, 2000
 
4) Gallais V, Lacour JP, Perrin C et al : Halo eczema around a histiocytofibroma : the Meyerson phenomenon. Ann Dermatol Venereol 120 : 617-620, 1993
PubMed
5) Hofer T : Meyerson phenomenon with a nevus flammeus. The different eczematous reactions within port-wine attains. Dermatology 205 : 180-183, 2002
 
6) Hofer T : Meyerson nevus as a primary patch of Gibert pityriasis rosea. A case report. Hautarzt 53 : 338-341, 2002
PubMed
P.238 掲載の参考文献
1) Ackerman AB : Differential Diagnosis in Dermatopathology. Lee & Febiger, Philadelphia, 1982, pp138-141
 
P.244 掲載の参考文献
1) 泉美貴 : メラノサイト系病変の検出にはMART-1/Melan-Aが一番! 私の一押し免疫染色. 検査と技術 35 : 852-853, 2007
 
2) 泉美貴 : 酵素抗体法 3 : 神経堤起源細胞性腫瘍. 皮膚科の臨床 48 : 1435-1441, 2006
 
3) Guerriere-Kovach PM, Hunt EL, Patterson JW et al : Primary melanoma of the skin and cutaneous melanomatous metastases : comparative histologic features and immunophenotypes. Am J Clin Pathol 122 : 70-77, 2004
PubMed
4) Prieto VG, Shea CR : Use of immunohistochemistry in melanocytic lesions. J Cutan Pathol 35 (Suppl 2) : 1-10, 2008
 
5) 原田 (泉) 美貴 : 悪性黒色腫における病理診断の最前線. 病理と臨床 17 (臨増) : 251-256, 1999
 
P.246 掲載の参考文献
1) Hoang MP, Duncan LM, Mihm MC et al : Case in Dermatopathology, Diagnostic pitfalls in dermatopathology. Knowledge Books and Software, Brisbane, 2008
 
2) Michie SA, Abel EA, Hoppe RT et al : Discordant expression of antigens between intraepidermal and intradermal T cells in mycosis fungoides. Am J Pathol 137 : 1447-1451, 1990
PubMed
3) Olsen E, Vonderheid E, Pimpinelli N et al. : Revisions to the staging and classification of mycosis fungoides and Sezary syndrome : a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 110 : 1713-1722, 2007
 
P.249 掲載の参考文献
1) Abbas O, Bhawan J : Epidermotropic lesions : a review. J Cutan Pathol 36 : 1037-1052, 2009
PubMed
2) Fung MA : Epidermotropism vs exocytosis of lymphocytes 101 : definition of the terms. J Cutan Pathol 36 : 525-529, 2010
 
3) Wu XS, Lonsdorf AS, Hwang ST : Cutaneous T-cell lymphoma : Roles for chemokines and chemokine receptors. J Invest Dermatol 129 : 1115-1119, 2009
PubMed
P.250 掲載の参考文献
1) Rongioletti F, Patterson JW, Rebora A : The histological and pathogenetic spectrum of cutaneous disease in monoclonal gammopathies. J Cutan Pathol 35 : 705-721, 2008
PubMed
P.256 掲載の参考文献
1) Eros N, Karolyi Z, Kovacs A et al : Intravascular B-cell lymphoma. J Am Acad Dermatol 47 : S260-S262, 2002
PubMed
2) McMenamin ME, Fletcher CD : Reactive angioendotheliomatosis : a study of 15 cases demonstrating a wide clinicopathologic spectrum. Am J Surg Pathol 26 : 685-697, 2002
PubMed
3) Rieger E, Soyer HP, LeBoit PE et al : Reactive angioendotheliomatosis or intravascular histiocytosis? An immunohistochemical and ultrastructural study in two cases of intravascular histiocytic cell proliferation. Br J Dermatol 140 : 497-504, 1999
PubMed
4) Lucas FV, Perez-Mesa C : Inflammatory carcinoma of the breast. Cancer 41 : 1595-1605, 1978
PubMed
P.258 掲載の参考文献
1) Chu T : Langerhans cell histiocytosis. Australasian J Dermatol 42 : 237-242, 2001
 
2) Longley BJ, Metcalfe DD : A proposed classification for mastocytosis incorporating molecular genetics. Hematol Oncol Clin North Am 14 : 697-701, 2000
PubMed
P.260 掲載の参考文献
1) Kong Y, Kong J, Shi D et al : Cutaneous Rosai-Dorfman disease. A clinical and histopathologic study of 25 cases in China. Am J Surg Pathol 31 : 341-350, 2007
PubMed
2) Kraus MD, Haley JC, Ruiz R et al : "Juvenile" xanthogranuloma. An immunophenotypic study with a reappraisal of histogenesis. Am J Surg Pathol 23 : 104-111, 2001
 
3) Wang K-H, Chen W-Y, Liu H-N et al : Cutaneous Rosai-Dorfman disease : clinicopathological profiles, spectrum and evolution of 21 lesions in six patients. Br J Dermatol 154 : 277-286, 2006
PubMed
P.263 掲載の参考文献
1) 笹島ゆう子 : 原発不明癌へのアプローチ. 診断に役立つ免疫組織化学, 病理と臨床 25 (臨増) : 10-14, 2007
 
2) 小川史洋, 新井栄一, 清水道生他 : 各臓器, 疾患で用いられる抗体とその応用, 皮膚. 診断に役立つ免疫組織化学, 病理と臨床 25 (臨増) : 184-190, 2007
 
P.266 掲載の参考文献
1) Swerdlow SH, Campo E, Harris NL et al (eds) : WHO Classification of Tumours. Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, 2008
 
2) 秋山隆, 定平吉都 : 各臓器, 疾患で用いられる抗体とその応用, 骨髄. 診断に役立つ免疫組織化学, 病理と臨床 25 (臨増) : 169-176, 2007
 
P.269 掲載の参考文献
1) Swerdlow SH, Campo E, Harris NL et al (eds) : WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, 2008
 

第4部 臨床との連携

P.282 掲載の参考文献
1) Argenziano G, Soyer HP, Chimenti S et al : Dermoscopy of pigmented skin lesions ; Results of a consensus meeting via the internet. J Am Acad Dermatol 48 : 679-693, 2003
PubMed
2) 池田重雄 (監) : カラーアトラスDermoscopy, 第2版. 金原出版, 東京, 2005
 
P.287 掲載の参考文献
1) Balch CM, Strawderman MH, Soong SJ et al : Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 27 : 6199-6206, 2009
 
2) 斎田俊明, 真鍋求, 竹之内辰也他. 皮膚悪性腫瘍診療ガイドライン. 日皮会誌 117 : 1855-1925, 2007 (以下のホームページでも閲覧可 : 日本皮膚科学会ホームページ : http://www.dermatol.or.jp/medical/guideline/ 日本医療機能評価機構EBM医療情報部 (Minds) : http://minds.jcqhc.or.jp)
 
3) Hayashi K, Koga H, Uhara H et al : High frequency 30-MHz sonography in preoperative assessment of tumor thickness of primary melanoma : usefulness in determining of surgical margin and indication of sentinel lymph node biopsy. Int J Clin Oncol 14 : 426-430, 2009
PubMed
4) Morton DL, Wen DR, Wong JH et al : Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127 : 392-399, 1992
PubMed
5) Morton DL, Thompson JF, Cochran AJ et al : Sentinel node biopsy or nodal observation in melanoma. N Engl J Med 355 : 1307-1317, 2006
 
6) Rosenberg SA, Dudley ME : Adoptive cell therapy for the treatment of patients with metastatic melanoma. Curr Opin Immunol 21 : 233-240, 2009
PubMed
7) Hocker TL, Singh MK, Tsao H : Melanoma genetics and therapeutic approaches in the 21st century : moving from the benchside to the bedside. J Invest Dermatol 128 : 2575-2595, 2008
 
P.289 掲載の参考文献
1) 石原和之, 池田重雄, 荒尾龍喜他 : 皮膚悪性腫瘍における固形がん薬物療法効果判定基準. Skin Cancer 2 : 1-13, 1987
 
2) Therasse P, Arbuck SG, Eisenhauer EA et al : New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92 : 205-216, 2000
PubMed
3) Eisenhauer EA, Theerasse P, Bogaerts J et al : New response evaluation criteria in solid tumours : Revised RECIST guideline (version 1.1). Eur J Cancer 45 : 228-247, 2009
 
4) 石原和之, 斎田俊明, 山本明史 : 皮膚悪性腫瘍における固形がん薬物療法効果判定基準 (改訂版). Skin Cancer 16 : 143-157, 2001
 
P.300 掲載の参考文献
1) Willemeze R, Jaffe ES, Burg G et al : WHO-EORTC classification for cutaneous lymphomas. Blood 105 : 3768-3785, 2005
 
2) Jaffe ES, Harris NL, Stein H et al : Introduction and overview of the classification of the lymphoid neoplasms. in Swerdlow SH, Campo E, Harris NL et al (eds) : "WHO Classification of Tumours. Haematopoietic and Lymphoid Tissues". IARC Press, Lyon, 2008, pp158-166.
 
3) Jaffe ES, Harris NL, Stein H et al : Classification of lymphoid neoplasms : the microscope as a tool for disease discovery. Blood 112 : 4384-4399, 2008
PubMed
4) Olsen E, Vonderheid E, Pimpinelli N et al : Revisions to the staging and classification of mycosis fungoides and Sezary syndrome : a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 110 : 1713-1722, 2007
 
5) Iwatsuki K, Satoh M, Yamamoto T et al : Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematological disorders. Arch Dermatol 142 : 587-595, 2006
 
6) 岩月啓氏, 河井一浩, 大塚幹夫他 : 皮膚悪性腫瘍ガイドライン II : 皮膚リンパ腫 (日本皮膚科学会・日本皮膚悪性腫瘍学会編) http://www.dermatol.or.jp/medical/guideline/pdf/hifu_rinpa.pdf
 
7) Kim YH, Willemze R, Pinpinelli N et al : TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome : a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 110 : 479-484, 2007
 
8) Ralfjiaer E, Willemze R, Paulli M et al : Primary cutaneous CD30-positive T-cell lymphoproliferative disorders. in Swerdlow SH, Campo E, Harris NL et al (eds) : "WHO Classification of Tumours. Haematopoietic and Lymphoid Tissues". IARC Press, Lyon, 2008, pp300-301
 
9) Willemze R, Jansen PM, Cerroni L et al : Subcutaneous panniculitis-like T-cell lymphoma : definition, classification, a prognostic factors : an EORTC Cutaneous Lymphoma Group Study of 83 cases. Blood 111 : 838-845, 2008
 
10) Oshimi K : Progress in understanding and managing natural killer-cell malignancies. Br J Haematol 139 : 532-544, 2007
PubMed
11) Oshimi K, Kawa K, Nakamura S et al : NK-cell neoplasms in Japan. Hematology 10 : 237-245, 2005
PubMed
12) Oono T, Arata J, Masuda T et al : Coexistence of hydroa vacciniforme and malignant lymphoma. Arch Dermatol 122 : 1306-1309, 1986
PubMed
13) Berti E, Tomasini D, Vermeer M et al : Primary cutaneous CD8-positive epidermotropic cytotoxic T-cell lymphomas : a distinct clinicopathologic entity with an aggressive clinical behavior. Am J Pathol 155 : 483-492, 1999
PubMed
14) Gaulard P, Berti E, Willemze R et al : Primary cutaneous peripheral T-cell lymphomas, rare subtypes. in Swerdlow SH, Campo E, Harris NL et al (eds) : "WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues". IARC Press, Lyon, 2008, 302-305
 
15) Paulli M, Viglio A, Vivenza D et al : Primary cutaneous large B-cell lymphoma of the leg : histologic analysis of a controversial clinicopathologic entity. Hum Pathol 33 : 937-943, 2002
 
16) Bekkenk MW, Jansen PM, Meijer CJLM et al : CD56+ hematological neoplasms presenting in the skin : a retrospective analysis of 23 new cases and 130 cases from the literature. Ann Oncol 15 : 1097-1108, 2004
PubMed
17) Suzuki R, Nakamura S, Suzumiya J et al : Blastic natural killer cell lymphoma/leukemia (CD56-positive blastic tumor). Prognostication and categorization according to anatomic sites of involvement, Cancer 104 : 1022-1031, 2005
PubMed
P.307 掲載の参考文献
1) Cheson B, Horning S, Coiffier B et al : Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 17 : 1244-1253, 1999
 
2) Stevens S, Ke M, Parry E et al : Quantifying skin disease burden in mycosis fungoides-type cutaneous T-cell lymphomas : the severity-weighted assessment tool (SWAT). Arch Dermatol 138 : 42-48, 2002
PubMed
3) Duvic M , Hymes K, Heald P et al : Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma : multinational phase II-III trial results. J Clin Oncol 19 : 2456-2471, 2001
 
4) Olsen EA, Kim YH, Kuzel TM et al : Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma. J Clin Oncol 25 : 3109-3115, 2007
PubMed
5) Olsen E, Vonderheid E, Pimpinelli N et al : Revisions to the staging and classification of mycosis fungoides and Sezary syndrome : a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 110 : 1713-1722, 2007
 
6) Kuo P, McClennan B, Carlson K et al : FDG-PET/CT in the evaluation of cutaneous T-cell lymphoma. Mol Imaging Biol 10 : 74-81, 2008
PubMed
7) 石井千寸, 天野正宏, 瀬戸山充他 : 体幹部, 下肢に多数の皮下結節で発症したsubcutaneous panniculitis-like T-cell lymphomaの1例. Skin Cancer 23 : 130-133, 2008
 
8) Cheson B, Pfistner B, Juweid M et al : Revised response criteria for malignant lymphoma. J Clin Oncol 25 : 579-586, 2007
PubMed
9) Juweid ME, Stroobants S, Hoekstra OS et al : Use of positron emission tomography for response assessment of lymphoma : consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol 25 : 571-578, 2007
 
10) Tsukasaki K, Hermine O, Bazarbachi A et al : Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma : a proposal from an international consensus meeting. J Clin Oncol 27 : 453-459, 2009
PubMed
11) 宇都宮與, 岡村純 : ATLL移植後のHTLV-1プロウイルス動態. 血液・腫瘍科 56 : 354-360, 2008
 
12) 岩田誠子, 木村宏 : EBV関連リンパ増殖性疾患における血中EBV定量の意義と問題点. 血液・腫瘍科 56 : 334-340, 2008
 
13) 岩月啓氏, 瀧川雅浩 : リンパ腫分類, 病態についての世界のトレンド. 皮膚アレルギーフロンティア 8 : 32-34, 2010
 
14) 日本LCH研究会 : JLSG-02プロトコール, 2006.05.01改訂
 
15) 山崎文登, 設楽利二, 馬場啓聡, 他 : ランゲルハンス細胞組織球症の病期決定および治療効果判定におけるFDG-PETの有用性. 小児がん 47 : 105-110, 2010
Medical*Online
16) 日本血液学会・日本リンパ網内系学会 (編) : 造血器腫瘍取扱い規約. 金原出版, 2010
 
P.317 掲載の参考文献
1) Association of Directors of Anatomic and Surgical Pathology : Standardization of surgical pathology report. Am J Surg Pathol 16 : 84-86, 1992
 
2) Herreid PA, Shapiro PE : Age distribution of Spitz nevus vs malignant melanoma. Arch Dermatol 132 : 352-353, 1996
PubMed
3) Hosler GA, Moresi JM, Barrett TL : Nevi with site-related atypia : a review of melanocytic nevi with atypical histologic features based on anatomic site. J Cutan Pathol 35 : 889-898, 2008
 
4) Kelly JW, Chamberlain AJ, Staples MP et al : Nodular melanoma. No longer as simple as ABC. Aust Fam Physician 32 : 706-709, 2003
PubMed
5) 泉美貴 : 皮膚 (爪を含む). 外科病理マニュアル, 病理と臨床, 26 (臨増) : 242-249, 2008
 
6) Apitz K : Uber die Pigmentbildung in den Zellkemen melanotischer Geschwulste : I. Beitrag zur Pathologie des Zellkemes. Virchow Arch A Pathol Anat 300 : 89-112, 1937
 
7) Rose DS : Nuclear pseudoinclusions in melanocytic naevi and melanomas. J Clin Pathol 48 : 676-677, 1995
PubMed
8) Reed RJ : Acral lentiginous melanoma. in Harmann W, Kay S, Reed RJ (eds) : "New Concepts in Surgical Pathology of the Skin". John Wiley & Sons Inc, New York, 1976, pp 89-90
 
9) 大原國章 : 悪性黒色腫-多様性についての考察-. Visual Dermatology 1 : 66-73, 2002
 
10) 泉美貴 : みき先生の皮膚病理診断ABC (3) メラノサイト系病変. 秀潤社, 2009, pp108-111
 
11) The Cochrane library (Michael Sladden). Surgical excision margins for primary cutaneous melanoma : a Cochrane review. www.cochranejournalclub.com (http://www.cochranejournalclub.com/surgical-excision-margins-clinical/)
 
12) McGovern VJ, Shaw HM, Milton GW : Histogenesis of malignant melanoma with an adjacent component of the superficial spreading type. Pathology 17 : 251-254, 1985
PubMed
13) Morton DL, Wen DR, Wong JH et al : Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127 : 392-399, 1992
PubMed
14) 日本皮膚悪性腫瘍学会 (編) : 皮膚悪性腫瘍取扱い規約, 第2版. 金原出版, 2010
 
15) van der Ploeg IM, Kroon BB, Antonini N et al : Comparison of three micromorphometric pathology classifications of melanoma metastases in the sentinel node. Ann Surg 250 : 301-304, 2009
PubMed
16) Frankel TL, Griffith KA, Lowe L et al : Do micromorphometric features of metastatic deposits within sentinel nodes predict nonsentinel lymph node involvement in melanoma? Ann Surg Oncol 15 : 2403-2411, 2008
PubMed
17) 土田哲也, 高杉彩子, 長島陽子 : 足底メラノーマ (初期病変) -ダーモスコピー所見と病理組織所見-. 病理と臨床 25 : 1260-1266, 2007
 

書評

最近チェックした商品履歴

Loading...